Large-cap Health Care company Medtronic has logged a -0.1% change today on a trading volume of 2,981,387. The average volume for the stock is 6,681,050.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Based in Dublin, Ireland the company has 95,000 full time employees and a market cap of $104,513,142,784. Medtronic currently offers its equity investors a dividend that yields 1.7% per year.
The company is now trading -13.68% away from its average analyst target price of $91.0 per share. The 27 analysts following the stock have set target prices ranging from $68.0 to $104.0, and on average give Medtronic a rating of buy.
Over the last 12 months MDT shares have declined by 0.0%, which represents a difference of -14.0% when compared to the S&P 500. The stock's 52 week high is $92.02 per share and its 52 week low is $68.84. Based on Medtronic's average net margin growth of 3.3% over the last 6 years, its core business remains strong and the stock price may recover in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 31,227,000 | 3,784,000 | 12 | -25.0 |
| 2022 | 31,686,000 | 5,062,000 | 16 | 33.33 |
| 2021 | 30,117,000 | 3,630,000 | 12 | -29.41 |
| 2020 | 28,913,000 | 4,806,000 | 17 | 13.33 |
| 2019 | 30,557,000 | 4,650,000 | 15 | 50.0 |
| 2018 | 29,953,000 | 3,104,000 | 10 |
